Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.26 EUR
343.00 M EUR
5.25 B EUR
116.68 M
About UCB
Sector
CEO
Jean-Christophe Tellier
Headquarters
Brussels
Website
Founded
1925
ISIN
BE0003739530
FIGI
BBG000BMYVN7
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange UCB S.A. stocks are traded under the ticker UNC.
We've gathered analysts' opinions on UCB S.A. future price: according to them, UNC price has a max estimate of 250.00 EUR and a min estimate of 145.00 EUR. Watch UNC chart and read a more detailed UCB S.A. stock forecast: see what analysts think of UCB S.A. and suggest that you do with its stocks.
Yes, you can track UCB S.A. financials in yearly and quarterly reports right on TradingView.
UCB S.A. is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
UNC earnings for the last half-year are 2.09 EUR per share, whereas the estimation was 1.76 EUR, resulting in a 18.58% surprise. The estimated earnings for the next half-year are 2.58 EUR per share. See more details about UCB S.A. earnings.
UCB S.A. revenue for the last half-year amounts to 2.79 B EUR, despite the estimated figure of 2.68 B EUR. In the next half-year revenue is expected to reach 2.98 B EUR.
UNC net income for the last half-year is 208.00 M EUR, while the previous report showed 32.00 M EUR of net income which accounts for 550.00% change. Track more UCB S.A. financial stats to get the full picture.
Yes, UNC dividends are paid annually. The last dividend per share was 0.95 EUR. As of today, Dividend Yield (TTM)% is 0.53%. Tracking UCB S.A. dividends might help you take more informed decisions.
UCB S.A. dividend yield was 1.21% in 2023, and payout ratio reached 52.65%. The year before the numbers were 1.27% and 42.23% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 16, 2024, the company has 9.08 K employees. See our rating of the largest employees — is UCB S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UCB S.A. EBITDA is 1.20 B EUR, and current EBITDA margin is 18.47%. See more stats in UCB S.A. financial statements.
Like other stocks, UNC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UCB S.A. stock right from TradingView charts — choose your broker and connect to your account.